Grzegorz Satała

Grzegorz Satała, MSc

 

e-mail: satala@if-pan.krakow.pl
phone: +4812 66 23 301

 

Research interests:

 

Publications:

  1. Sagnes, C.; Fournet, G.; Satala, G.; Bojarski, A. J. ; Joseph, B. New 1-arylindoles based serotonin 5-HT antagonists. Synthesis and binding evaluation studies. Eur. J. Med. Chem. 201475C, 159-168 (http://www.ncbi.nlm.nih.gov/pubmed/24531229)
  2. Canale, V.; Guzik, P.; Kurczab, R.; Verdie, P.; Satala, G.; Kubica, B.; Pawlowski, M.; Martinez, J.; Subra, G.; Bojarski, A. J.; Zajdel, P. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT and 5-HT receptor ligands. Eur. J Med. Chem. 201478C, 10-22 (http://www.ncbi.nlm.nih.gov/pubmed/24675176)
  3. Handzlik, J.; Bojarski, A. J.; Satala, G.; Kubacka, M. ; Sadek, B.; Ashoor, A.; Siwek, A.; Wiecek, M.; Kucwaj, K.; Filipek, B.; Kiec-Kononowicz, K. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives. Eur. J Med. Chem. 201478, 324-339 (http://www.ncbi.nlm.nih.gov/pubmed/24691057)
  4. Chłoń-Rzepa, G.; Zmudzki, P.; Pawlowski, M.; Wesolowska, A.; Satala, G.; Bojarski, A. J.; Jabłoński, M.; Kalinowska-Tłuścik, J. New 7-arylpiperazinylalkyl-8-morpholin-4-yl-purine-2, 6-dione derivatives with anxiolytic activity–Synthesis, crystal structure and structure–activity study. J. Mol. Struc. 20141067, 243-251 (http://www.sciencedirect.com/science/article/pii/S0022286014002865)
  5. Waszkielewicz, A. M.; Gunia, A.; Szkaradek, N.; Pytka, K.; Siwek, A.; Satala, G.; Bojarski, A. J.; Szneler, E.; Marona, H. Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety. Bioorg. Med. Chem. Lett. 201323, 4419-4423 (http://www.ncbi.nlm.nih.gov/pubmed/23787101)
  6. Lacivita, E.; De Giorgio, P.; Patarnello, D.; Niso, M.; Colabufo, N. A.; Berardi, F.; Perrone, R.; Satala, G.; Duszynska, B.; Bojarski, A. J.; Leopoldo, M. Towards metabolically stable 5-HT receptor ligands: a study on 1-arylpiperazine derivatives and related isosters. Exp. Brain Res. 2013230, 569-582 (http://www.ncbi.nlm.nih.gov/pubmed/23571499)
  7. Wrobel, M. Z.; Chodkowski, A.; Herold, F.; Gomolka, A. ; Kleps, J.; Mazurek, A. P.; Plucinski, F.; Mazurek, A.; Nowak, G.; Siwek, A.; Stachowicz, K.; Slawinska, A.; Wolak, M.; Szewczyk, B.; Satala, G.; Bojarski, A. J.; Turlo, J. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1. Eur. J. Med. Chem. 201363, 484-500 (http://www.ncbi.nlm.nih.gov/pubmed/23524160)
  8. Chlon-Rzepa, G.; Zmudzki, P.; Satala,G.; Duszynska, B.; Partyka, A.; Wrobel, D.; Jastrzebska-Wiesek, M.; Wesolowska, A.; Bojarski, A. J.; Pawlowski, M.; Zajdel, P. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation. Pharmacol. Rep. 201365, 15-29 (http://www.ncbi.nlm.nih.gov/pubmed/23563020)
  9. Grychowska, K.; Marciniec, K.; Canale, V.; Szymiec, M. ; Glanowski, G.; Satala, G.; Maslankiewicz, A.; Pawlowski, M.; Bojarski, A. J.; Zajdel, P. Quinolinesulfonamides of Aryloxy-/Arylthio-ethyl Piperidines: Influence of an Arylether Fragment on 5-HT1A /5-HT7 Receptor Selectivity. Arch. Pharm. (Weinheim). 2013346, 180-188 (http://www.ncbi.nlm.nih.gov/pubmed/23381952)
  10. Obniska, J.; Chlebek, I.; Kamiński, K.; Bojarski, A. J.; Satala, G. Anticonvulsant Activity and 5-HT1A/5-HT7 Receptors Affinity of Piperazine Derivatives of 3,3-Diphenyl- and 3,3-Dimethyl-succinimides. Lett. Drug Des. Discov. 201310, 173-182
  11. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Grychowska, K.; Satala, G.; Duszynska, B.; Lenda, T.; Siwek, A.; Nowak, G.; Partyka, A.; Wrobel, D.; Jastrzebska-Wiesek, M.;  Bojarski, A. J.; Wesolowska, A.; Pawlowski, M. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT(1A)/5-HT(2A)/5-HT(7) and dopamine D(2)/D(3) receptors. Eur. J. Med. Chem. 201360, 42-50 (http://www.ncbi.nlm.nih.gov/pubmed/23279866)
  12. Obniska, J.; Chlebek, I.; Kamiński, K.; Bojarski, A. J.; Satala, G. Anticonvulsant Activity and 5-HT1A/5-HT7 Receptors Affinity of Piperazine Derivatives of 3,3-Diphenyl- and 3,3-Dimethyl-succinimides. Lett. Drug Des. Discov. 201310, 173-182
  13. Obniska, J.; Chlebek, I.; Kamiński, K.; Bojarski, A. J.; Satała, G. Synthesis, anticonvulsant activity and 5-HT1A/5-HT7 receptors affinity of 1-[(4-arylpiperazin-1-yl)-propyl]-succinimides. Pharmacol. Rep. 201264, 326-336 (http://www.ncbi.nlm.nih.gov/pubmed/22661183)
  14. Tokarski, K.; Zelek-Molik, A.; Duszynska, B.; Satała, G.; Bobula, B.; Kusek, M.; Chmielarz, P.; Nalepa, I.; Hess, G. Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus. Pharmacol. Rep. 201264, 2556-65 (http://www.ncbi.nlm.nih.gov/pubmed/22661174)
  15. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Satala, G.; Duszynska, B.; Bojarski, A. J.; Partyka, A.; Jastrzebska-Wiesek, M.; Wrobel, D.; Wesolowska, A.; Pawlowski, M. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation. Bioorg. Med. Chem. 201220, 1545-1556 (http://www.ncbi.nlm.nih.gov/pubmed/22277589)
  16. Zajdel, P.; Kurczab, R.; Grychowska, K.; Satała, G.; Pawłowski, M.; Bojarski, A. J. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists. Eur. J. Med. Chem. 201256, 348-360 (http://www.ncbi.nlm.nih.gov/pubmed/22926225).
  17. Zajdel, P.; Marciniec, K.; Maslankiewicz, A.; Paluchowska, M. H.; Satala, G.; Partyka, A.; Jastrzebska-Wiesek, M.; Wrobel, D.; Wesolowska, A.; Duszynska, B.; Bojarski, A. J.; Pawlowski, M. Arene- and quinoline-sulfonamides as novel 5-HT(7) receptor ligands. Bioorg. Med. Chem. 201119, 6750-6759 (http://www.ncbi.nlm.nih.gov/pubmed/22001327).
  18. Zajdel, P.; Król, J.; Grychowska, K.; Pawłowski, M.; Subra, G.; Nomezine, G.; Martinez, J.; Satała, G.; Bojarski, A. J.; Zhou, Z.; O’Donnel, M. J.; Scott, W. L. Solid-Phase Synthesis of Arylpiperazine Derivatives and Implementation of the Distributed Drug Discovery (D3). Molecules 201116, 4104-4121 (http://www.mdpi.com/1420-3049/16/5/4104).

 

Participation in research projects:

 

  • EXtention of academia-based PLATFORM to antidepressant hits discovery (PLATFORMex), Pol-Nor/198887/73/2013, function: executor, 2013 –
  • Innovative therapies for neurodegenerative and neurodevelopmental diseases based on mGlu receptor allosteric modulators – Allosterix, NCBiR 178469, function: executor, 2013 –
  • Demeter – Depression – mechanisms – therapy, WND-POIG.01.01.02-12.004/09 (http://www.de-me-ter.pl), function: executor, 2010-2014.
  • Allosteric modulation – new strategy in pharmacotherapy. Identification of the psychotropic properties of glutamatergic receptor ligands of group III. WND-POIG.01.03.01-12-100/08 (http://modall.pl), function: executor, 2011-2012.
  • Creating an academia-based platform to discover substances acting on serotonergic or glutamatergic systems as potential new antidepressant or anxiolytic drugs. PNRF-103-AI-1/07 (http://cns-platform.eu/main.html), function: executor, 2010-2011.
  • Antagonists of 5-HT6 receptor as advanced antipsychotic drugs with procognitive properties, UDA-POIG.01.03.01-12-063/09-02 (http://www.prokog.pl), function: executor, 2010-2013.

Scientific reports:

 

a) posters:

  1. Canale, V.; Kurczab, R.; Steczko, M.; Tytro, K.; Satała, G.; Pawłowski, M.; Bojarski, A.J.; Zajdel, P.; Synthesis of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments and their biological evaluation for 5-HT7 receptors; VIIIth Joint Meeting on Medicinal Chemistry, 30.06-04.07.2013, Lublin, Poland, Book of Abstracts, p.P-7.
  2. Dela, A.; Wójcik, R.; Duszyńska, B.; Satała, G.; Dybała, M.; Siwek, A.; Handzlik, J.; Bojarski, A.; Kieć-Kononowicz, K.; Influence of the substituent(s) at aromatic rings at arylidene phenylpiperazine hydantoin on affinity and selectivity to 1-adrenoreceptor, 5-HT1, 5-HT6 and 5-HT7 serotonine receptors; VIIIth Joint Meeting on Medicinal Chemistry, 30.06-04.07.2013, Lublin, Poland, Book of Abstracts, p.P-9.
  3. Zajdel, P.; Marciniec, K.; Maślankiewicz, A.; Canale, V.; Satała, G.; Duszyńska, B.; Partyka, A.; Wróbel, D.; Bojarski, A.J.; Wesołowska, A. ; Pawłowski, M.; Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of Aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopaminę D2/D3 ; 31th Camerino-Cyprus’Noordwijkershout Symposium, 19-23.05.2013, Camerino, Italy, Book of Abstracts, p.P-96.
  4. Zajdel, P.; Partyka, A.; Canale, V.; Wróbel, D.; Powrożnik, B.; Kubowicz, P.; Żmudzki, P.; Marciniec, K.; Satała, G.; Pękala, E.; Bojarski, A.J.; Wesołowska, A.; Pawłowski, M.; Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole – their multireceptor profile, metabolic stability, antidepressant and antipsychotic activity; Vth BBBB International Conference, 26-28.09.2013, Athens, Greece, Book of Abstracts, p.PP050.
  5. Zajdel, P.; Kurczab, R.; Canale, V.; Marciniec, K.; Grychowska, K.; Satała, G.; Pawłowski, M.; Bojarski, A.J.; Arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists; Vth BBBB International Conference, 26-28.09.2013, Athens, Greece, Book of Abstracts, p.PP051.
  6. Grychowska, K.; Marciniec, K.; Canale, V.; Satała, G.; Maślankiewicz, A.; Bojarski, A.J.; Pawłowski, M.; Zajdel, P.; Wpływ fragmentu aryloeterowego na selektywność 5-HT7/5-HT1A receptorową w grupie chinolinosulfonamidowych pochodnych aryloxy-/arylthioetylopiperydyn; III Konferencja Naukowa Doktorantów Wydziału Lekarskiego i Farmaceutycznego UJ CM, 09-10.05.2013, Zeszyty Naukowe Towarzystwa Doktorantów Uniwersytetu Jagiellońskiego, Nauki Ścisłe, Nr 6 (1/2013), p.57.
  7. Staroń, J.; Warszycki, D.; Kalinowska-Tłuścik, J.; Satała, G.; Bojarski, A.J.; The use of bioisosteric strategy to design and analyse 5-HT6 ligands binding mode;  III Konferencja Naukowa Doktorantów Wydziału Lekarskiego i Farmaceutycznego UJ CM, 09-10.05.2013, Zeszyty Naukowe Towarzystwa Doktorantów Uniwersytetu Jagiellońskiego, Nauki Ścisłe, Nr 6 (1/2013), p.164. Poster
  8. Wróbel, D.; Jastrzębska-Więsek, M.; Partyka, A.; Wąsik, A.; Zajdel, P.; Satała, G.; Bojarski, A.J.; Pawłowski, M.; Wesołowska, A.; Antidepressant-like activity of newly synthesized quinoline and isoquinoline analogues of aripiprazole; Neuronus 2013, IBRO & IRUN Neuroscience Forum, 09-11.05.2013, Kraków, Poland, Book of Abstracts, p.36
  9. Wesołowska, A.; Partyka, A.; Wróbel, D.; Wasik, A.; Chłoń, G.; Satała, G.; Bojarski, A.J.; Central activity of novel LCAP derivative with a very high affinity for 5-HT1A receptors; The XVIIIth International Congress of the Polish Pharmacological Society, 23-25.05.2013, Poland, Pharmacol. Rep., 2013, 65, Suppl., 9-7
  10. Partyka, A.; Wróbel, D.; Wasik, A.; Jastrzębska-Więsek, M.; Chłoń, G.; Satała, G.; Bojarski, A.J.;  Wesołowska, A.; 7-Arylpiperazinylalkyl derivatives of purine -2,6-dione in functional and behavioral experiments; The Twenty-second Day of Neuropsychopharmacology, 24.05.2013, Kazimierz Dolny, Poland, Pharmacol. Rep., 2013, 65, Suppl., p.129
  11. Warszycki, D.; Satała, G.; Staroń, J.; Bojarski, A.J.; Bioisosteric replacement in search for novel 5-HT6R ligands; 5th Symposium of the Polish Bioinformatics Society, 25-27.05.2012, Gdańsk, Poland, Book of Abstracts, p.Talk19. Abstract Poster
  12. Zajdel, P.; Kurczab, R. ; Grychowska, K.; Szymiec, M.; Glanowski, G.; Kamiński, K.; Satała, G.; Pawłowski, M.; Bojarski, A.J.; The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of arylxyethyl- and arylthioethyl piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists; The Eight Multidisciplinary Conference on Drug Research, 30.05-01.06.2012, Rawa Mazowiecka, Poland, Book of Abstracts, p.74. Abstract
  13. Wróbel, D.; Jastrzębska-Więsek, M.; Partyka, A.; Zajdel, P.; Pawlowski, M.; Marciniec, K.; Maślankiewicz, A.; Bojarski, A.; Satała, G.; Wesolowska, A.; Potential antidepressant, but not anitpsychotic, activity of new 2,3-dichlorophenylpiperazines containing quinoline- or isoquinoline-sulfonamide moieties in behavioral models in mice; 28th CINP World Congress of Neuropsychopharmacology, 03-07.06.2012, Stockholm, Sweden, Book of Abstracts, p.77.
  14. Guzik, P.; Canale, V.; Verdie, P.; Kurczab, R.; Satała, G.; Pawłowski, M.; Martinez, J.; Subra, G.; Bojarski, A.J.; Zajdel, P.; Long-Chain Arylpiperazine Derivatives with Cyclic Amino Acid Amide Fragments as Potential 5-HT7 Receptor Ligands; The 5th Conversatory of Medicinal Chemistry, 13-15.09.2012, Lublin, Poland, Book of Abstracts, p.P-93.Abstract
  15. Zajdel, P.; Kurczab, R.; Grychowska, K.; Szymiec, M. ; Glanowski, G.; Satała, G.; Pawłowski, M.; Bojarski, A.J.; The Multiobjective Based Design, Synthesis and Evaluation of the Arylsulfonamide/amide Derivatives of Arylxyethyl- and Arylthioethyl Piperidines and Pyrrolidines as a Novel Class of Potent 5-HT7 Receptor Antagonists; The 5th Conversatory of Medicinal Chemistry, 13-15.09.2012, Lublin, Poland, Book of Abstracts, p.P-92.Abstract
  16. Satała, G.; Nędza, K.; Bojarski, A.J.; Cooperative Properties of Zinc Binding to 5-HT7 Receptor – Pilot Studies; Book of Abstracts, p.P-63. Abstract Poster
  17. Morak-Młodawska, B.; Bojarski, A.J.; Satała, G.; Pluta, K.; Jeleń, M.; New Dipirydothiazine Derivatives – Potential Inhibitors of Dopaminergic and Serotoninergic Receptors; The 5th Conversatory of Medicinal Chemistry, 13-15.09.2012, Lublin, Poland, Book of Abstracts, p.P-45. Abstract
  18. Grychowska, K.; Marciniec, K.; Szymiec, M.; Satała, G.; Bojarski, A.J.; Maślankiewicz, A.; Pawłowski, M.; Zajdel, P.; An Influence of Aryloxy-/Arylthio-ethyl Fragment on 5-HT1A/5-HT7 Receptor Selectivity in a Group of Quinolinesulfonamide Derivatives of Aryloxyethyl- and Arylthioethyl- Piperidines; The 5th Conversatory of Medicinal Chemistry, 13-15.09.2012, Lublin, Poland, Book of Abstracts, p.P18. Abstract
  19. Czopek, A.; Zajdel, P. ; Satała, G.; Bojarski, A.J.; Pawłowski, M.; An Impact of Halogen Position in 4-Phenylpiperazine of LCAPs with Spirohydantoins on the 5-HT1A/5-HT7 Receptor Selectivity; The 5th Conversatory of Medicinal Chemistry, 13-15.09.2012, Lublin, Poland, Book of Abstracts, p.P-12. Abstract
  20. Morak-Młodawska, B.; Pluta, K.; Jeleń, M.; Bojarski, A.J.; Satała, G.; Suwińska, K.; New Phenothiazine Analogues – Synthesis, Structure and Biological Activities; 6th Summer School Medicinal Chemistry, 26-28.09.2012, Regensburg, Germany, Book of Abstracts, p.251. Abstract
  21. Mocanu, O.; Voinea, R. ; Badarau, E.; Grig-Alexa, I.; Panek, J.; Morisset-Lopez, S.; Satała, G.; Bojarski, A.J.; Finaru, A.L.; Suzenet, F.; Guillaumet, G.; New benzimidazolone derivatives as ligands for the 5-HT7 receptors; 22nd International Symposium on Medicinal Chemistry, EFMC-ISMC, 02-06.09.2012, Berlin, Germany, Book of Abstracts
  22. Bugno, R.; Duszyńska, B.; Satała, G.; Mordalski, S.; Chmielarz, P.; Nalepa, I.; Bojarski, A.J.; Searching of novel leads for 5-HT7 receptor antagonists – selectivity hints from molecular modeling studies; VII Joint Meeting on Medicinal Chemistry, 26-27.06.2011, Catania, Italy, Book of Abstracts, p.189. Abstract Poster
  23. Warszycki, D.; Kristiansen, K.; Kurczab, R.; Satała, G.; Mordalski, S.; Sylte, I.; Bojarski, A.J.; Extensive pharmacophore modeling studies on 5-HT1A receptor ligands – single hypothesis vs. linear combinations; VII Joint Meeting on Medicinal Chemistry, 26-27.06.2011, Catania, Italy, Book of Abstracts, p.186. Abstract Poster
  24. Zajdel, P.; Marciniec, K.; Maślankiewicz, A.; Grychowska, K.; Satała, G.; Partyka, A.; Jastrzębska-Więsek, M.; Wróbel, D.; Wesolowska, A.; Bojarski, A.J.; Pawłowski, M.; Novel 5-HT7 receptor ligands N-terminated with quinolinesulfoamoyl moieties; VII Joint Meeting on Medicinal Chemistry, 26-27.06.2011, Catania, Italy, Book of Abstracts, p.200. Abstract
  25. Sagnes, C.; Fournet, G.; Satała, G.; Bojarski, A.J.; Joseph, B.; New N-arylindoles based serotonin 5-HT7 ligands: Synthesis and binding affinity studies; 47th International Conference on Medicinal Chemistry, 06-08.07.2011, Lyon, France, Book of Abstracts, p.P051.
  26. Staroń, J.; Warszycki, D.; Satała, G.; Bugno, R.; Bojarski, A.J.; Bioisosterism, the use in designing 5-HT6 receptor ligands; 4th International Symposium on Advances in Synthetic and Medicinal Chemistry, 21-25.08.2011, St. Petersburg, Russia, Book of Abstracts, p.176. Abstract Poster
  27. Dela, A.; Wójcik, R.; Duszyńska, B.; Satała, G.; Handzlik, J.; Bojarski, A.J.; Kieć-Kononowicz, K.; Influence of the Substituent(s) at Aromatic Rings at Arylidene Phenylpiperazine Hydantoin on Affinity to 5-HT6 and 5-HT7 Serotonine Receptors; The 4th Conversatory of Medicinal Chemistry, 08-10.09.2011, Lublin, Poland, Book of Abstracts, p.P-8.Abstract
  28. Satała, G.; Duszyńska, B.; Nędza, K.; Bojarski, A.J.; Exploring the Effect of Radioligand Depletion on Affinity Determinations in the Dopamine D2 Binding Assay; The 4th Conversatory of Medicinal Chemistry, 08-10.09.2011, Lublin, Poland, Book of Abstracts, p.P-54. Abstract Poster
  29. Zajdel, P.; Marciniec, K.; Maślankiewicz, A.; Satała, G.; Wróbel, D.; Wesolowska, A.; Bojarski, A.J.; Pawłowski, M.; Synthesis and Pharmacological Evaluation of Quinolone- and Isoquinoline-Sulfonamides of Long-Chain Arylpiperazines as 5-HT7 Antagonists; The 4th Conversatory of Medicinal Chemistry, 08-10.09.2011, Lublin, Poland,  Book of Abstracts, p.P-78. Abstract
  30. Zajdel, P.; Marciniec, K.; Piskorz, S.; Maślankiewicz, A.; Satała, G.; Partyka, A.; Jastrzębska-Więsek, M.; Wróbel, D.; Wesołowska, A.; Bojarski, A.J.; Pawłowski, M.; Chinolinosulfonamidy jako nowe ligandy receptorów 5-HT7; 54th PTChem and SiTPChem Annual Meeting, 18-22.09.2011, Lublin, Poland, Book of Abstracts, p.389. Abstract
  31. Wróbel, D.; Partyka, A.; Jastrzębska-Więsek, M.; Zajdel, P.; Pawłowski, M.; Bojarski, A.J.; Satała, G.; Wesolowska, A.; Efekty funkcjonalne nowych sulfonoamidowych pochodnych 3-chinoliny w mysim modelu depresji;  Konferencja Naukowa Doktorantów Wydział Lekarskiego CMUJ, 11.05.2011, Kraków, Poland, Zeszyty Naukowe Towarzystwa Doktorantów UJ, 2011, 2, p.105.
  32. Wróbel, D.; Partyka, A.; Jastrzębska-Więsek, M.; Zajdel, P.; Pawłowski, M.; Bojarski, A.J.; Satała, G.; Wesolowska, A.; Efekty funkcjonalne nowych sulfonoamidowych ligandów receptora 5-HT7 w zwierzęcych modelach depresji u myszy; V Kopernikańskie Seminarium Doktoranckie, 16-18.06.2011, Toruń, Poland, Book of Abstracts, p.86
  33. Bugno, R.; Satała, G.; Duszyńska, B.; Kurczab, R.; Bojarski, A.J.; Examination of 5-HT6 receptor affinity in the group of arylsulfonamide derivatives; The Seventh Multidisciplinary Conference on Drug Research, 09-12.05.2010, Zakopane, Poland, Book of Abstracts, p.25. Abstract Poster
  34. Satała, G.; Bugno, R.; Duszyńska, B.; Kurczab, R.; Bojarski, A.J.; Verification of Virtual Screening Results for 5-HT6 Receptor in In Vitro Experiments; 3rd Conversatory on Medicinal Chemistry, 20-22.09.2010, Lublin, Poland, Book of Abstracts, p.PP-12. Abstract Poster

b) speeches

  1. Warszycki, D.; Prymula, K.; Kurczab, R.; Satała, G.; Bojarski, A.J.; The Implementation of an Expert System to Search for Novel Substances Acting on Serotonergic and Glutamatergic Systems; 3rd Conversatory on Medicinal Chemistry, Book of Abstracts, p.K-3. Abstract